AMN Healthcare Services financials
$34.95+2.01%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.73B | $2.98B | $3.79B | $5.24B | $3.98B | $2.39B | $2.22B | $2.14B | $1.99B | $1.90B |
| Gross profit | $774.1M | $919.4M | $1.25B | $1.72B | $1.31B | $791.8M | $743.5M | $696.4M | $644.4M | $619.7M |
| Gross margin | 28.3% | 30.8% | 33.0% | 32.7% | 32.9% | 33.1% | 33.5% | 32.6% | 32.4% | 32.6% |
| Operating income | -$94.6M | -$102.7M | $338.4M | $647.1M | $478.0M | $149.3M | $176.9M | $202.8M | $212.4M | $191.6M |
| Net income | -$95.7M | -$147.0M | $210.7M | $444.1M | $327.4M | $70.7M | $114.0M | $141.7M | $132.6M | $105.8M |
| Net margin | −3.5% | −4.9% | 5.6% | 8.5% | 8.2% | 3.0% | 5.1% | 6.6% | 6.7% | 5.6% |
| Diluted EPS | $-2.48 | $-3.85 | $5.36 | $9.90 | $6.81 | $1.48 | $2.40 | $2.91 | $2.68 | $2.15 |
| EBITDA | $189.8M | $293.6M | $507.2M | $784.2M | $581.7M | $243.5M | $235.1M | $243.9M | $244.6M | $221.3M |
| Operating cash flow | $269.5M | $320.4M | $372.2M | $653.7M | $305.4M | $256.8M | $224.9M | $227.0M | $160.5M | $133.9M |
| Free cash flow | $233.8M | $239.5M | $268.5M | $577.9M | $251.8M | $219.1M | $189.6M | $191.8M | $134.0M | $112.0M |
| Diluted shares | 38.5M | 38.2M | 39.3M | 44.9M | 48.0M | 47.7M | 47.6M | 48.7M | 49.4M | 49.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $34.0M | $10.6M | $32.9M | $64.5M | $180.9M | $29.2M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $767.1M | $1.06B | $1.30B | $843.5M | $842.3M | $862.6M |
| Total assets | $2.09B | $2.42B | $2.92B | $2.89B | $3.13B | $2.35B |
| Total liabilities | $1.45B | $1.71B | $2.09B | $1.84B | $1.97B | $1.53B |
| Shareholders' equity | $642.1M | $706.6M | $831.3M | $1.04B | $1.16B | $819.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology